The National Women’s Health Network (NWHN) supports access to safe and effective reproductive health technologies, services, and information without restrictions driven by ideology.

The Campaign defends women’s sexual and reproductive health and autonomy against anti-choice threats that seek to undermine access to contraception and abortion care.  We also promote access to unbiased, accurate information about how women can protect themselves from unintended pregnancy and sexually transmitted infections (STIs).

We are committed to creating the world where people no longer experience obstacles in obtaining the reproductive and sexual health care that is right for them. We are passionate about gender equity and expanding healthcare to vulnerable populations, including women of color, young women, poor women, and LGBTQ people.

Current NWHN advocacy priorities for the Sexual and Reproductive Health and Autonomy Campaign include:

  • Expanding and protecting coverage for abortion care services in public and private health insurance.
  • Ensuring women’s access to safe and effective medication abortion by defending against attacks on women’s health and science and by supporting women who want to use pills on their own to end a pregnancy.
  • Challenging efforts to direct women toward any particular contraceptive method and ensuring that people are provided comprehensive, scientifically accurate information about the full range of contraceptive options in a medically ethical and culturally competent manner in order to ensure that each person is supported in identifying the method that best meets their needs.
  • Establishing over-the-counter access to affordable emergency contraception without medically unjustified age restrictions.
  • Promoting evidence-based information about the safety and effectiveness of female condoms in the United States, and working to increase visibility and use of them by the public.
  • Ensuring that women’s options for addressing sexual problems are safe and effective, including pushing back against approval of drugs for which risks exceed the benefits.
  • Using evidence-based research to move oral contraceptives over the counter (OC OTC) in a way that is accessible to low-income women and does not undermine the insurance protected guaranteed by the ACA.


Updated October 2016